Evidence map›Paper›PMID 42680967›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2026

Metabolomics Data Processing Using the Asari Toolkit.

Joshua Mitchell, Jasmine Chong, Shuzhao Li

Abstract read
PubMed Publisher
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Joshua MitchellThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Jasmine ChongThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA.
Shuzhao LiThe Jackson Laboratory for Genomic Medicine, Farmington, CT, USA. shuzhao.li@jax.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Asari is a software tool for metabolomics data processing, which is designed from the ground up to address issues in reproducibility, performance and interoperability by introducing new algorithms and data structures. It is significantly faster than other tools and offers qualities that are suitable for large-scale metabolomic and exposomic analyses. The reusable data structures and modular libraries enabled the rapid development of a full-scale pipeline that includes QA/QC, MS/MS integration, annotation, and extension to untargeted stable isotope tracing data. This chapter provides an overview of the key concepts and designs in Asari, step-by-step applications to metabolomics data processing and annotation, and resources related to both LC-MS and GC-MS data.

Indexed as

Computational BiologyMetabolomicsSoftwareAlgorithmsGas Chromatography-Mass SpectrometryHumansLiquid Chromatography-Mass SpectrometryTandem Mass SpectrometryAsariData processingMetabolomicsPipeline

Identifiers

PMID42680967

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.